Treace Medical Concepts (TMCI)
(Delayed Data from NSDQ)
$4.43 USD
+0.26 (6.24%)
Updated May 9, 2024 04:00 PM ET
After-Market: $4.37 -0.06 (-1.35%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 0.00% |
ABR | 2.71 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.91 |
Next Year | -0.79 |
EPS (TTM) | -0.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 49.69M | 49.75M | 222.84M | 263.18M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 50.20M | 50.12M | 223.63M | 266.62M |
Low Estimate | 49.30M | 49.20M | 222.50M | 259.70M |
Year ago Sales | 41.95M | 40.76M | 187.12M | 222.84M |
Year over Year Growth Est. | 18.45% | 22.04% | 19.09% | 18.10% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.28 | -0.91 | -0.79 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.23 | -0.27 | -0.84 | -0.69 |
Low Estimate | -0.31 | -0.28 | -1.00 | -0.91 |
Year ago EPS | -0.20 | -0.28 | -0.81 | -0.91 |
Year over Year Growth Est. | -35.00% | 0.00% | -12.35% | 13.41% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.28 | -0.91 | -0.79 |
7 Days Ago | -0.27 | -0.28 | -0.91 | -0.79 |
30 Days Ago | -0.27 | -0.28 | -0.91 | -0.79 |
60 Days Ago | -0.27 | -0.28 | -0.91 | -0.79 |
90 Days Ago | -0.17 | -0.16 | -0.50 | -0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.28 | -0.91 | -0.79 |
Zacks Consensus Estimate | -0.27 | -0.28 | -0.91 | -0.79 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.10 | -0.28 | -0.20 | NA |
Estimate | -0.30 | -0.09 | -0.26 | -0.23 | NA |
Difference | 0.00 | -0.01 | -0.02 | 0.03 | 0.00 |
Surprise | 0.00% | -11.11% | -7.69% | 13.04% | -1.44% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more